ASN 2021

Patients with gout have significantly greater intercritical inflammation and lumbosacral spine monosodium urate crystal (MSU) deposition when compared with those without the condition, and trend toward greater deposition among...

In the phase IV open-label PROTECT trial of pegloticase therapy (pegylated recombinant uricase) in treating severe gout in renal transplant recipients, 89% of patients achieved the primary endpoint of serum uric acid (sUA) less...

In a dialysis-dependent population, patients with gout showed a higher cardiovascular comorbidity burden and an increased risk of hospitalization and mortality, compared with patients without gout. In addition, older age,...

The following learning pathways will help attendees locate sessions in their area of interest: Acute Kidney Injury Bone and Mineral Metabolism Cell and Transport Physiology Chronic Kidney Disease Development and Pediatrics...

Browse or search Kidney Week 2021 Abstracts by type, category, presentation date, author first or last name, or keyword. Find out what’s new this year at Kidney Week 2021.

With increasing uncertainties around variants of the COVID-19 virus, ASN has canceled plans for the in-person component of ASN Kidney Week 2021 in San Diego, CA, and chosen a fully virtual experience for attendees. Access the...

Using 2017 USRDS data, researchers identified dialysis patients aged 18 and older with Medicare as the primary payer. Baseline characteristics and comorbid conditions for patients with gout who were dialysis-dependent were...

Prior research has shown that pegloticase therapy for uncontrolled gout does not require renal adjustments and is effective across all stages of CKD. Pegloticase with immunomodulating (IMM) co-therapy demonstrated an increased...

Since patients with CKD are at increased risk for gout and alkalinization solubilizes uric acid, investigators sought to determine if baseline bicarbonate or change in bicarbonate was an independent predictor of incident gout in...

With evidence that gout highly impacts patients with advanced CKD, through increased healthcare utilization and higher cardiovascular and bone/joint comorbidity and patients with uncontrolled gout (UCG) show to have an even...